Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ascendis Pharma A/S ASND

Healthcare Biotechnology
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).


NDAQ:ASND - Post by User

Ascendis Pharma A/S
<< Previous
 Bullboard Posts
User Avatar Image
(229)
•••
Post by whytestockson Sep 16, 2024 3:16pm
23 Views
Post# 36225928

ASND Price Target Alert: $200.00. Issued by Goldman Sachs

ASND Price Target Alert: $200.00. Issued by Goldman Sachs
Breaking News: $ASND ASND Price Target Alert: $200.00. Issued by Goldman Sachs2024-09-16 15:00:05 ET Paul Choi from Goldman Sachs issued a price target of $200.00 for ASND on 2024-09-16 12:06:00. The adjusted price target was set to $200.00. At the time of the announcement, ASND was trading at $142.26. The overall price target consensus is at $174...ASND - ASND Price Target Alert: $200.00. Issued by Goldman Sachs

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities